Latest Campaign Updates

Society of Biology joins AllTrials

The Society of Biology, a UK learned society for academics, industry, and researchers in biology, has just joined AllTrials. This is fantastic, the Society represents 90 organisation and 14,000 individual members.

Here is the Society of Biology’s statement:
The Society of Biology is pleased to announce its support for aims of the AllTrials petition. The Society […]

24th October 2014|

You can help shape a new global statement on clinical trial reporting

We have a chance to get the most influential health body in the world – the World Health Organisation (WHO) – to say something strong on the need for the results of all clinical trials to be publicly reported. Following all of our pressure, the WHO has decided it needs to say something about […]

23rd October 2014|

Read moving comments in support of clinical trial transparency

The UK’s Health Research Authority (HRA) has published the feedback it received to its clinical trial transparency proposals. Look at pages 6-13 for some of the most compelling and moving reasons for clinical trial transparency that we’ve seen.

Hundreds of you wrote to the HRA in July to support its proposals. Thanks to your support, […]

21st October 2014|

Visualising publication bias in MS trials

A new data visualisation showing the results of 106 clinical trials in multiple sclerosis over the past 30 years reveals possible publication bias. The tool was developed by the Multiple Sclerosis Discovery Forum (MSDF) and is the first in a series of visualisations they are creating in the hope that people will discover unexpected […]

16th October 2014|

Respond to WHO consultation on reporting results of clinical trials

Many signatories to AllTrials have wondered why the World Health Organisation has never had a policy on reporting the results of clinical trials. The WHO has now resolved that it needs one.
It is seeking public comments on a draft statement, which you can find here.
This is potentially a really significant step. We have a chance […]

15th October 2014|

Reminder emails get researchers to report results

More researchers will post the results of their trials if they are sent an email reminder according to a recent study published in The BMJ. Since 2007, the FDA has required people in the US to register their trials on ClinicalTrials.gov before they begin and to post summary results within one year of completion […]

15th October 2014|

Recovered trials: Two trials on children’s head lice treatments

Ian Burgess told us about two trials on head lice treatments that had been kept hidden for 14 and 20 years. These trials involved 546 people (mostly children) in Bangladesh and the UK. Dr Burgess’ group managed to publish both of the trials this year in open access journals.

I have been wanting to publish […]

14th October 2014|

GIMBE featured in Italian newspaper video report

One of Italy’s largest newspapers, Corriere della Sera, has posted a video with interviews about the AllTrials campaign. The video features Nino Cartabellotta, President of the GIMBE Foundation, and Silvio Garattini, Director of the Mario Negri Institute for Pharmacological Research.

GIMBE is an Italian academic organisation that promotes evidence-based medicine. They joined the AllTrials campaign in […]

13th October 2014|

Support pharmaceutical doctors’ draft Code on clinical trial reporting

Please respond today to the Faculty of Pharmaceutical Medicine’s (FPM) consultation on whether it should tell its members they must register and report all clinical trials. The FPM represents doctors who develop and monitor the safety of medicines and medical devices. Its members work for academic institutes, regulators and pharmaceutical companies in the UK […]

9th October 2014|

Transparency risks “misuse of data” says commissioner due to oversee regulation of medicines in EU

Yesterday, the likely European Commissioner for industry who will oversee the regulation of medicines and the EMA said there are risks that need to be balanced with greater clinical trial transparency. MEPs have been questioning the candidates for the new European Commission and, if approved by MEPs, Elżbieta Bieńkowska will lead the industry department […]

3rd October 2014|